NMDA but not AMPA receptor antagonists impair the delay-interposed radial maze performance of rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 249-253

  Li, Hong Bin ^a   Matsumoto, Kinzo ^a   Yamamoto, Minoru ^b   Watanabe, Hiroshi ^a  

^a Toyama Medical and Pharmaceutical University   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

AMPA antagonist; CG19755; Delay interposed radial maze task; MK801; NMDA antagonist; Spatial working memory; YM90K

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; WORKING MEMORY;

ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; PIPECOLIC ACIDS; PSYCHOMOTOR PERFORMANCE; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SPACE PERCEPTION;

ANIMALIA;

EID: 0030879222     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00015-4     Document Type: Article

References (30)

1. Abraham W. C., Mason S. E. Effects of the NMDA receptor/channel antagonists CPP and MK801 on hippocampal field potentials and long-term potentiation in anaesthetized rats. Brain Res. 462:1988;40-46.
2. Arai A, Lynch G. Factors regulating the magnitude of long term potentiation induced by theta pattern stimulation. Brain Res. 598:1992;173-184.
3. Barnes C. A. Spatial learning and memory processes. the search for their neurobiological mechanisms in the rat Trends Neurosci. 11:1988;163-169.
4. Bettler B., Mulle C. Review. neurotransmitter receptors II: AMPA and kainate receptors Neuropharmacology. 34:1995;123-139.
5. Bliss T. V. P., Collingridge G. L. A synaptic model of memory. long-term potentiation in the hippocampus Nature. 361:1993;31-39.
6. Butelman E. R. A novel NMDA antagonist, MK801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacol. Biochem. Behav. 34:1989;13-16.
7. Butters N., Pandya D., Stein D, Rosen J. A search for the spatial engram within the frontal lobes of monkeys. Acta Neurobiol. Exp. Warsaw. 32:1972;305-329.
8. Collingridge G. L., Lester R. A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41:1989;143-210.
9. Desimore R. Is dopamine a missing link? Nature. 376:1995;549-550.
10. Edmonds B., Gibb A. J., Colquhoun D. Mechanisms of activation of glutamate receptors and the time course of excitatory synaptic currents. Annu. Rev. Physiol. 57:1995;495-519.
11. Freeman J. J., Stanton M. Medial prefrontal cortex lesions and spatial delayed alternation in the developing rat. recovery or sparing? Behav. Neurosci. 106:1992;924-932.
12. Funahashi S., Bruce C. J., Goldman-Rakic P. S. Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex. J. Neurophysiol. 61:1989;331-349.
13. Gill R., Nordholm L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal cerebral ischemia model. Brain Res. 580:1992;35-43.
14. Ito I., Tanabe S., Khoda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physiol. (Lond.). 424:1990;533-543.
15. Li H. B., Matsumoto K., Tohda M., Yamamoto M., Watanabe H. NMDA- but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task. Brain Res. 725:1996;268-271.
16. Morris R. G. M., Anderson E., Lynch G., Baudry M. Selective impairment of learning and blockade of LTP by an NMDA receptor antagonist, AP5. Nature. 319:1986;774-776.
17. Nadel L., MacDonald L. Hippocampus. cognitive map or working memory? Behav. Neural Biol. 29:1980;405-409.
18. Ohta H., Matsumoto K., Watanabe H. The interaction between central cholinergic and peripheral β-adrenergic systems on radial maze performance in rats. Brain Res. 622:1993;353-356.
19. O'Keefe J., Speakman A. Single unit activity in the rat hippocampus during a spatial memory task. Exp. Brain Res. 68:1987;1-27.
20. Olton D. S., Becker J. T., Handelmann G. E. Hippocampus, space and memory. Behav. Brain Sci. 2:1979;487-533.
21. Racine R. T., Milgram N. W., Hafner S. Long term potentiation phenomena in the rat limbic forebrain. Brain Res. 260:1983;217-231.
22. Sato K., Morimoto K., Yamada N., Kuroda S, Hayabara T. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo. Brain Res. 683:1995;279-282.
23. Sheardown M. J., Nielsen E. O., Hansen A. J., Jacobsen P., Honore T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. a neuroprotectant for cerebral ischemia Science. 247:1990;571-574.
24. Shimizu-Sasamata M., Kawasaki-Yatsugi S., Okada M., Sakamoto S., Yatsugi S., Togami J., Hatanaka K., Ohmori J., Koshiya K., Usuda S., Murase K. YM90K. pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist J. Pharmacol. Exp. Ther. 276:1996;84-92.
25. Staubli U., Rogers G., Lynch G. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad. Sci. USA. 91:1994;777-781.
26. Tandon P., Liu Z., Stafstrom C. E., Sarkisian M., Warner S. J., Mikati M., Yang Y., Holmes G. L. Long-term effects of excitatory amino acid antagonists NBQX and MK801 on the developing brain. Dev. Brain Res. 95:1996;256-262.
27. Ungerleider L. G. Functional brain imaging studies of cortical mechanisms for memory. Science. 270:1995;769-775.
28. Ward J., Mason S. E., Abraham W. C. Effects of the NMDA antagonists CPP and MK801 on radial maze performance in rats. Pharmacol. Biochem. Behav. 35:1989;785-790.
29. Watanabe M. Reward expectancy in primate prefrontal neurons. Nature. 382:1996;629-632.
30. Zivkovic I., Thomson D. M., Bertolino M., Uzunov D., Dibella M., Costa E., Guidotti A., 7-Chloro-3-methyl-3 4-dihydro-2H-1, 2 4-benzothiadiazine S, S-dioxide (IDRA 21 a benzothiadiazine derivative that enhanced cognition by attenuating DL-alpha-amino-2,3-hydroxy-5-methyl-3-oxo-4-isoxazolepropionic acid (AMPA) receptor desensitization. J. Pharmacol. Exp. Ther. 272:1995;300-309.